{ "schemaVersion": 2, "eyebrow": "Psychiatry", "title": "Avoidant Personality Disorder", "summary": "Diagnose avoidant personality disorder through persistent, impairing interpersonal avoidance and negative self-appraisal, while separating it from social anxiety disorder, psychotic-spectrum illness, depression, and trauma-related avoidance. Use longitudinal history, collateral data, functional assessment, and targeted treatment of comorbidity.", "seoDescription": "Clinical diagnosis and management of avoidant personality disorder, including differentiation from social anxiety disorder and treatment of comorbidity.", "clinicalQuestion": "How should clinicians diagnose avoidant personality disorder, distinguish it from social anxiety disorder, and structure management?", "specialty": "Psychiatry", "audience": "U.S. physicians and medical trainees", "tags": [ "avoidant personality disorder", "AvPD", "social anxiety disorder", "personality disorders", "DSM-5-TR", "personality functioning" ], "keyTakeaways": [ "Establish avoidant personality disorder through a longitudinal, cross-situational pattern of social inhibition, perceived inadequacy, and rejection sensitivity that produces clinically significant dysfunction; obtain collateral history when feasible. [18][22]", "Do not treat AvPD as interchangeable with generalized social anxiety disorder: overlap is substantial, but emotional guardedness and pervasive interpersonal impairment may add clinically meaningful information beyond social-anxiety severity. [8][14][19]", "Assess personality functioning and trait domains in addition to categorical criteria when complexity, diagnostic uncertainty, or treatment planning warrants dimensional formulation. [15][17]", "No medication is FDA-approved for AvPD, and evidence for direct pharmacologic benefit is limited; use SSRIs or SNRIs for a co-occurring social anxiety disorder and treat other comorbid disorders on their own indications. [18]", "Avoid prognosis based on presumed lifelong diagnostic stability: AvPD diagnosis shows moderate longitudinal stability, with an estimated 10-year diagnostic stability correlation of 0.51. [19]" ], "sections": [ { "id": "diagnostic-entry-point", "eyebrow": "Assessment", "heading": "Confirm a pervasive personality pattern before assigning AvPD", "intro": "The clinical task is to document enduring dysfunction rather than infer AvPD from social avoidance alone.", "paragraphs": [ "Use a longitudinal interview to determine whether avoidance, feelings of inadequacy, and hypersensitivity to rejection are persistent across relationships, work or school, and unfamiliar social settings. A formal diagnosis requires DSM-5-TR criteria and a comprehensive assessment incorporating personal history, mental-status examination, functional impairment, and, when possible, collateral information. [18][22]", "Anchor the diagnosis to impairment. Clinically important AvPD is distinguished from temperament or situational shyness by a pattern that constrains occupational functioning, close relationships, and participation in desired activities. The patient may desire connection but avoid engagement because anticipated criticism, rejection, embarrassment, or perceived inferiority dominates behavioral choices. [7][18]", "Document onset and course, including school attendance, employment transitions, friendships, intimate relationships, family relationships, and prior treatment engagement. Persistence should be established across time and settings; a new or sharply worsening avoidant presentation should trigger reassessment for a mood disorder, anxiety disorder, trauma-related condition, substance-related condition, psychotic-spectrum disorder, or a medical contributor rather than reflexively assigning a personality diagnosis. [18][22]" ], "bullets": [ "Ask for concrete avoided situations: applying for work, speaking in meetings, dating, attending group activities, requesting help, or pursuing advancement despite stated interest. [18]", "Obtain collateral history when the patient consents, particularly when self-report minimizes impairment, interpersonal history is sparse, or the presentation could reflect chronic depression, psychosis, or autism-spectrum social-communication differences. [18][22]", "Record current suicide risk, self-harm history, major depression, substance use, trauma symptoms, and psychotic symptoms before attributing withdrawal to AvPD. Comorbid psychiatric illness is common in clinically impaired avoidant presentations. [14][18]" ], "subsections": [], "table": { "caption": "Clinical features that redirect the differential diagnosis of pervasive social avoidance. [8][14][18][19]", "columns": [ "Presentation pattern", "Diagnostic interpretation", "Next clinical action" ], "rows": [ [ "Avoidance centers on scrutiny, embarrassment, or performance situations, with otherwise preserved capacity for intimacy", "Prioritize social anxiety disorder assessment; AvPD and generalized social anxiety disorder have substantial overlap. [8][14]", "Assess social-anxiety severity, depression, and functional impairment; determine whether avoidance is pervasive across self-concept and close relationships. [8][14]" ], [ "Pervasive perceived inadequacy, rejection sensitivity, guardedness, and avoidance despite desire for connection", "Supports AvPD formulation when the pattern is enduring and functionally impairing. [7][18]", "Complete DSM-5-TR assessment and formulate personality functioning, traits, and comorbidity. [18][22]" ], [ "Social withdrawal driven by reduced interest in affiliation rather than fear of criticism or rejection", "Consider schizoid personality features or other causes of detachment rather than AvPD. [18]", "Clarify desire for closeness, emotional range, and the role of fear versus indifference in avoidance. [18]" ], [ "Odd beliefs, unusual perceptual experiences, suspiciousness, or disorganized communication", "Consider schizotypal personality disorder or a psychotic-spectrum disorder. [4]", "Assess psychosis-spectrum symptoms, functional decline, and need for specialty psychiatric evaluation. [4]" ], [ "Avoidance emerges with depressive anhedonia, trauma reminders, intoxication, withdrawal, or acute functional decline", "A state-dependent disorder may be primary or may be amplifying preexisting personality pathology. [18][22]", "Treat and reassess the active disorder; do not rely on a cross-sectional personality diagnosis. [18][22]" ] ] } }, { "id": "separate-avpd-from-social-anxiety", "eyebrow": "Differential diagnosis", "heading": "Separate AvPD from generalized social anxiety disorder without forcing a false dichotomy", "intro": "The distinction affects formulation, treatment targets, and expectations for functional change.", "paragraphs": [ "Generalized social anxiety disorder and AvPD frequently co-occur and share social inhibition, fear of negative evaluation, and avoidance. In patients with generalized social anxiety disorder, a categorical AvPD diagnosis may function partly as a marker of greater social-anxiety severity and depression; however, emotional guardedness may identify additional impairment not captured by the social-anxiety diagnosis alone. [8][14]", "Evaluate whether the patient’s central concern is circumscribed fear during social or performance exposure, or a broader and enduring interpersonal identity organized around defectiveness, anticipated rejection, and reluctance to enter relationships. The latter pattern supports an AvPD formulation, especially when the patient avoids intimacy, opportunities, and new relationships despite a stated wish for affiliation. [7][18]", "Do not assume AvPD is merely severe social anxiety disorder. Community and clinical observations indicate that many people with AvPD do not meet concurrent social anxiety disorder criteria, while patients with both conditions generally have greater symptom burden and psychiatric comorbidity than those with social anxiety disorder alone. [14][19]" ], "bullets": [ "Ask whether the patient avoids only evaluative situations or also avoids disclosure, closeness, invitations, occupational advancement, and activities that require interpersonal uncertainty. [18]", "Assess emotional guardedness directly: difficulty revealing thoughts or feelings because disclosure is expected to bring humiliation, criticism, or rejection can guide a more personality-focused formulation. [8][14]", "When both diagnoses apply, document both rather than selecting one label; then define separate targets for social anxiety, depressive symptoms, avoidance behavior, interpersonal functioning, and personality-related self-appraisal. [14][18]" ], "subsections": [], "table": { "caption": "AvPD and generalized social anxiety disorder: clinically useful distinctions. [8][14][18][19]", "columns": [ "Domain", "More consistent with generalized social anxiety disorder", "More consistent with AvPD" ], "rows": [ [ "Primary avoided context", "Social or performance situations involving possible scrutiny. [8][14]", "Broad social, occupational, and intimate contexts in which rejection or inadequacy is anticipated. [7][18]" ], [ "Self-concept", "May be affected by anxiety-related negative evaluation. [8][14]", "Persistent feelings of inadequacy and broad expectation of rejection are central. [7][18]" ], [ "Interpersonal style", "Avoidance may lessen outside feared social exposures. [8][14]", "Emotional guardedness and reluctance to engage even when connection is desired may be prominent. [8][14]" ], [ "Clinical formulation", "Anxiety-disorder treatment targets may predominate. [18]", "Include personality functioning, enduring traits, interpersonal patterns, and comorbid anxiety or mood disorders. [15][17][18]" ] ] } }, { "id": "structured-diagnostic-formulation", "eyebrow": "Diagnostic formulation", "heading": "Use dimensional assessment when categorical diagnosis does not explain severity or treatment needs", "intro": "A dimensional formulation can clarify impairment, traits, and resource needs.", "paragraphs": [ "DSM-5-TR categorical diagnosis remains a clinical option, but contemporary personality-disorder frameworks also emphasize severity of impairment in self and interpersonal functioning and maladaptive traits. In ICD-11 and the DSM-5 Alternative Model for Personality Disorders, personality-functioning severity is positioned as a central clinical decision variable for diagnosis, prognosis, treatment intensity, and service planning. [15][17]", "When the presentation is diagnostically complex, assess identity, self-direction, empathy, and intimacy, then characterize trait domains relevant to the case. For avoidant presentations, negative affectivity and detachment are particularly pertinent; anxiousness belongs to negative affectivity, while withdrawal, anhedonia, and intimacy avoidance belong to detachment. [16][17]", "Structured assessment can improve diagnostic discipline when personality pathology is suspected but history is inconsistent or comorbidity obscures the clinical picture. The SCID-5-AMPD Module I assesses level of personality functioning; its use may be particularly helpful in specialty settings where differentiating severity and traits changes treatment planning. [17]" ], "bullets": [ "Use categorical DSM-5-TR criteria to establish the diagnosis, then add a dimensional description when it clarifies degree of interpersonal dysfunction or trait targets. [18][22]", "Specify co-occurring generalized social anxiety disorder, major depressive disorder, other anxiety disorders, substance use disorders, trauma-related disorders, or psychotic-spectrum symptoms rather than subsuming them under AvPD. [14][18]", "Avoid using psychological tests as a substitute for a longitudinal clinical evaluation; psychological testing is not generally required when sufficient history is available. [22]" ], "subsections": [], "table": { "caption": "Dimensional targets that can sharpen an AvPD formulation. [15][16][17]", "columns": [ "Assessment domain", "Clinical finding", "Treatment-planning implication" ], "rows": [ [ "Personality functioning", "Impairment in identity, self-direction, empathy, or intimacy. [15][17]", "Match treatment intensity and goals to functional impairment rather than symptom count alone. [15][17]" ], [ "Negative affectivity", "Prominent anxiousness and rejection-related distress. [16]", "Track anxiety triggers, affect regulation, and co-occurring anxiety or depressive disorders. [16][18]" ], [ "Detachment", "Withdrawal, anhedonia, or intimacy avoidance. [16]", "Distinguish fear-driven avoidance from diminished affiliative interest and target behavioral disengagement. [16][18]" ], [ "Severity over time", "Moderate diagnostic stability rather than fixed lifelong course. [19]", "Reassess functioning and diagnosis as comorbidity, environment, and treatment response change. [19]" ] ] } }, { "id": "management", "eyebrow": "Treatment", "heading": "Build management around psychotherapy engagement and treatment of comorbidity", "intro": "Direct evidence for a disorder-specific medication strategy is limited.", "paragraphs": [ "Start management by naming a shared functional target, such as returning to work, sustaining a relationship, attending a treatment group, or participating in previously avoided activities. AvPD is associated with persistent interpersonal and occupational dysfunction, so symptom reduction alone is an incomplete treatment endpoint. [7][18]", "Psychotherapy is the principal treatment modality, although the evidence base does not establish a single universally preferred approach for AvPD. Cognitive therapy and psychodynamic approaches have been studied, and treatment should explicitly address avoidance, negative self-appraisal, interpersonal expectations, and engagement barriers rather than treating the diagnosis as medication-responsive. [7][18]", "Medication should not be presented as primary treatment for AvPD itself. There are no FDA-approved medications for AvPD, psychotropic medications are generally described as ineffective for the disorder, and evidence for cross-over benefit from social-anxiety pharmacotherapy is limited. If a co-occurring social anxiety disorder is present, SSRIs or SNRIs may be used for that disorder; select and monitor medication according to the comorbid diagnosis rather than AvPD alone. [18]", "Treat co-occurring depression, social anxiety disorder, other anxiety disorders, substance use, trauma-related symptoms, or psychotic-spectrum illness with diagnosis-specific care. This is especially important because AvPD with generalized social anxiety disorder is associated with greater psychiatric comorbidity and symptom severity than generalized social anxiety disorder without AvPD. [14][18]" ], "bullets": [ "Before referral, identify anticipated barriers to attendance: fear of negative evaluation by the therapist, shame after missed appointments, reluctance to speak in groups, and avoidance of discussing interpersonal setbacks. These are treatment targets, not evidence of low motivation. [18]", "Use treatment goals that can be observed longitudinally: attendance consistency, re-engagement after missed visits, initiation of valued social contact, work or school participation, and capacity to discuss feared rejection. [7][18]", "If prominent perceptual disturbances, suspiciousness, odd beliefs, or functional deterioration suggest schizotypal or psychotic-spectrum illness, prioritize psychiatric reassessment rather than escalating an AvPD-focused psychotherapy plan alone. [4]" ], "subsections": [ { "heading": "Medication boundaries", "paragraphs": [ "Do not extrapolate evidence from borderline personality disorder to AvPD. In borderline personality disorder, a Cochrane review found that antipsychotics, antidepressants, and mood stabilizers may have little to no effect on overall BPD symptom severity versus placebo, with very low-certainty evidence, and effects on self-harm and suicide-related outcomes were very uncertain. Those results reinforce the need to prescribe pharmacotherapy for a defined comorbid indication rather than for undifferentiated personality pathology. [11]" ], "bullets": [ "Avoid routine antipsychotic, antidepressant, or mood-stabilizer prescribing solely for avoidant traits in the absence of a separately established indication. [11][18]" ] } ], "table": { "caption": "Management decisions for AvPD and common co-occurring clinical patterns. [14][18]", "columns": [ "Clinical pattern", "Primary management focus", "Medication role" ], "rows": [ [ "AvPD without a clearly diagnosable active comorbid disorder", "Psychotherapy focused on avoidance, self-appraisal, interpersonal functioning, and treatment engagement. [7][18]", "No FDA-approved pharmacotherapy for AvPD; do not use medication as a default disorder-specific intervention. [18]" ], [ "AvPD with generalized social anxiety disorder", "Address social avoidance and broader personality-related interpersonal impairment concurrently. [8][14]", "SSRIs or SNRIs may be used for the social anxiety disorder; evidence for direct AvPD benefit is limited. [18]" ], [ "AvPD with depression or other psychiatric comorbidity", "Treat the co-occurring disorder using its established treatment plan while maintaining personality-focused functional goals. [14][18]", "Prescribe for the comorbid diagnosis, not for AvPD as an isolated target. [18]" ], [ "Avoidance with psychotic-spectrum features", "Re-evaluate for schizotypal personality disorder or psychotic-spectrum illness and arrange psychiatric assessment. [4]", "Base pharmacotherapy on the confirmed psychotic-spectrum or other comorbid diagnosis. [4]" ] ] } }, { "id": "monitoring-and-prognosis", "eyebrow": "Follow-up", "heading": "Monitor function and engagement, not diagnostic labels alone", "intro": "The longitudinal plan should measure whether avoidance is narrowing the patient’s life less over time.", "paragraphs": [ "At follow-up, assess functional domains directly: work or school participation, frequency and quality of social contact, capacity for intimacy, participation in desired activities, and treatment attendance. Reassess current depression, anxiety severity, substance use, trauma symptoms, and suicide risk because changes in these conditions can alter both avoidant behavior and diagnostic interpretation. [14][18][22]", "Use missed appointments and progressive withdrawal as clinical data. Contact patterns, willingness to reschedule, ability to discuss shame or anticipated criticism, and avoidance of treatment tasks can identify active barriers requiring modification of the therapeutic plan. [18]", "Discuss prognosis without therapeutic nihilism. AvPD can be persistent, but longitudinal data indicate moderate—not absolute—diagnostic stability: a reported 10-year stability estimate was r=0.51. Track improvement through functioning and relationships, and revise the formulation when symptoms become better explained by a current mood, anxiety, trauma-related, substance-related, or psychotic-spectrum condition. [19][22]" ], "bullets": [ "Reassess the working diagnosis when social withdrawal becomes new, rapidly progressive, psychotic, substance-related, or temporally linked to a mood episode. [4][18][22]", "Escalate suicide-risk assessment and intervention whenever severe depression, self-harm, hopelessness, intoxication, or acute psychosocial loss accompanies withdrawal; AvPD should not distract from acute risk management. [18][22]", "Review the treatment formulation after meaningful functional change rather than assuming that chronic interpersonal avoidance is immutable. [19]" ], "subsections": [], "table": { "caption": "Follow-up domains for avoidant personality disorder. [18][19][22]", "columns": [ "Domain to review", "Concerning finding", "Clinical response" ], "rows": [ [ "Treatment engagement", "Repeated nonattendance or abrupt disengagement after perceived criticism. [18]", "Address anticipated rejection, clarify the therapeutic rupture, and revise engagement strategies. [18]" ], [ "Functional range", "Ongoing avoidance of work, school, relationships, or valued activities. [7][18]", "Set a concrete functional treatment target and assess co-occurring anxiety or depression. [18]" ], [ "Diagnostic fit", "New odd beliefs, perceptual symptoms, suspiciousness, or major functional decline. [4]", "Reassess for schizotypal or psychotic-spectrum illness. [4]" ], [ "Course", "Persistent symptoms despite treatment, or apparent remission after improvement in comorbidity. [19][22]", "Reevaluate personality functioning and active comorbid diagnoses rather than assuming a fixed course. [19][22]" ] ] } } ], "faq": [], "references": [ { "number": 1, "title": "Personality disorders - Symptoms, diagnosis and treatment | BMJ Best Practice", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-us/489", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com" }, { "number": 2, "title": "Ten-Year Course of Borderline Personality Disorder", "detail": "jamanetwork.com", "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1107231", "authors": "jamanetwork.com", "host": "jamanetwork.com" }, { "number": 3, "title": "State-Dependent Cross-Brain Information Flow in ...", "detail": "jamanetwork.com", "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2646393", "authors": "jamanetwork.com", "host": "jamanetwork.com" }, { "number": 4, "title": "Diagnosis and treatment of schizotypal personality disorder: evidence from a systematic review | Schizophrenia", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41537-018-0062-8", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 5, "title": "Neurobiological correlates of personality dimensions in ...", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-025-85989-x.pdf", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 6, "title": "Combined treatment of borderline personality disorder with interpersonal psychotherapy and pharmacotherapy: Predictors of response", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165178115000281", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 7, "title": "Avoidant Personality Disorder - Alden - Major Reference Works - Wiley Online Library", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/abs/10.1002/9781118625392.wbecp250", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com" }, { "number": 8, "title": "Avoidant personality disorder in individuals with generalized social anxiety disorder: What does it add?", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0887618512000692", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 9, "title": "CLINICAL GUIDELINES FOR PSYCHOTHERAPY FOR PATIENTS WITH BORDERLINE PERSONALITY DISORDER - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0193953X05701519", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 10, "title": "A network analysis of DSM-5 avoidant personality disorder diagnostic criteria", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0191886921008333", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 11, "title": "Pharmacological interventions for people with borderline personality disorder - Stoffers-Winterling, JM - 2022 | Cochrane Library", "detail": "www.cochranelibrary.com", "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012956.pub2/full", "authors": "www.cochranelibrary.com", "host": "www.cochranelibrary.com" }, { "number": 12, "title": "Borderline Personality Disorder in Adolescence | Pediatrics", "detail": "publications.aap.org", "url": "https://publications.aap.org/pediatrics/article/134/4/782/32909/Borderline-Personality-Disorder-in-Adolescence", "authors": "publications.aap.org", "host": "publications.aap.org" }, { "number": 13, "title": "Pharmacological interventions for people with borderline ...", "detail": "www.cochranelibrary.com", "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012956.pub2/references", "authors": "www.cochranelibrary.com", "host": "www.cochranelibrary.com" }, { "number": 14, "title": "Avoidant Personality Disorder in Individuals with Generalized Social Anxiety Disorder: What Does It Add? - PMC", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417304?term=%22J+Anxiety+Disord%22%5Bjour%5D", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 15, "title": "Diagnostic accuracy of severity measures of ICD-11 and DSM-5 personality disorder: clarifying the clinical landscape with the most up-to-date evidence", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10265646", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" }, { "number": 16, "title": "The Differential Profile of Social Anxiety Disorder (SAD) and Avoidant Personality Disorder (APD) on the Basis of Criterion B of the DSM-5-AMPD in a College Sample", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6839665", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" }, { "number": 17, "title": "A Psychometric Analysis of the Structured Clinical Interview for the DSM-5 Alternative Model for Personality Disorders Module I (SCID-5-AMPD-I): Level of Personality Functioning Scale", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8167914", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" }, { "number": 18, "title": "Avoidant Personality Disorder - StatPearls - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK559325", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 19, "title": "Avoidant personality disorder: current insights", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5848673", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" }, { "number": 20, "title": "Avoidant Personality Disorder", "detail": "pubmed.ncbi.nlm.nih.gov", "url": "https://pubmed.ncbi.nlm.nih.gov/32644751", "authors": "pubmed.ncbi.nlm.nih.gov", "host": "pubmed.ncbi.nlm.nih.gov" }, { "number": 21, "title": "Examination of DSM-5 Section III avoidant personality ...", "detail": "pubmed.ncbi.nlm.nih.gov", "url": "https://pubmed.ncbi.nlm.nih.gov/28703479", "authors": "pubmed.ncbi.nlm.nih.gov", "host": "pubmed.ncbi.nlm.nih.gov" }, { "number": 22, "title": "Personality Disorder - StatPearls - NCBI Bookshelf - NIH", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK556058", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 23, "title": "PSYCHOLOGICAL AND PSYCHOSOCIAL TREATMENTS IN THE MANAGEMENT OF BORDERLINE PERSONALITY DISORDER - Borderline Personality Disorder - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK55410", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 24, "title": "The role of avoidant and obsessive-compulsive personality disorder traits in matching patients with major depression to cognitive behavioral and psychodynamic therapy: A replication study", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165032715310752", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" } ], "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.", "citations": [ { "number": 1, "title": "Personality disorders - Symptoms, diagnosis and treatment | BMJ Best Practice", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-us/489", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com", "snippet": "When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance. Personality disorders are a relatively common, chronic pattern of perceptual and behavioural abnormalities. Personality dis", "score": 0.98558 }, { "number": 2, "title": "Ten-Year Course of Borderline Personality Disorder", "detail": "jamanetwork.com", "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1107231", "authors": "jamanetwork.com", "host": "jamanetwork.com", "snippet": "by JG Gunderson · 2011 · Cited by 1259 — ContextBorderline personality disorder (BPD) is traditionally considered chronic and intractable.ObjectiveTo compare the course of BPD's psychopathology.", "score": 0.98539 }, { "number": 3, "title": "State-Dependent Cross-Brain Information Flow in ...", "detail": "jamanetwork.com", "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2646393", "authors": "jamanetwork.com", "host": "jamanetwork.com", "snippet": "by E Bilek · 2017 · Cited by 81 — The neural correlates of anomalous habituation to negative emotional pictures in borderline and avoidant personality disorder patients.", "score": 0.95813 }, { "number": 4, "title": "Diagnosis and treatment of schizotypal personality disorder: evidence from a systematic review | Schizophrenia", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41537-018-0062-8", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "# Diagnosis and treatment of schizotypal personality disorder: evidence from a systematic review. The main objective of this review was to evaluate studies on the diagnosis, treatment, and course of schizotypal personality disorder and to provide a clinical guidance on the basis of that evaluation. ", "score": 0.98431 }, { "number": 5, "title": "Neurobiological correlates of personality dimensions in ...", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-025-85989-x.pdf", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "Neurobiological correlates of personality dimensions in borderline personality disorder using graph analysis of functional connectivity Francesca D’Adda1,9, Giovanni Sighinolfi2,9, Micaela Mitolo2,3, Mauro Scala4,5,6, Lucia Guidi2, Lorenzo Motta2, Lorenzo Cirignotta7, David Neil Manners2,8, Caterina", "score": 0.94547 }, { "number": 6, "title": "Combined treatment of borderline personality disorder with interpersonal psychotherapy and pharmacotherapy: Predictors of response", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165178115000281", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "# Combined treatment of borderline personality disorder with interpersonal psychotherapy and pharmacotherapy: Predictors of response. * •Predictors of response to combination of fluoxetine and interpersonal therapy in BPD. A previous study of our group found that combined therapy with interpersona", "score": 0.869120356 }, { "number": 7, "title": "Avoidant Personality Disorder - Alden - Major Reference Works - Wiley Online Library", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/abs/10.1002/9781118625392.wbecp250", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com", "snippet": "This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. ## Avoidant Personality Disorder. Avoidant personality disorder (AvPD) is a prevalent, moderately stable, dysfunctional pattern of personali", "score": 0.8167505803809647 }, { "number": 8, "title": "Avoidant personality disorder in individuals with generalized social anxiety disorder: What does it add?", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0887618512000692", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "# Avoidant personality disorder in individuals with generalized social anxiety disorder: What does it add?☆. Avoidant personality disorder (AvPD) has a high level of symptom overlap and comorbidity with generalized social anxiety disorder (GSAD). A binary diagnosis of AvPD alone adds little beyond a", "score": 0.7736896007136658 }, { "number": 9, "title": "CLINICAL GUIDELINES FOR PSYCHOTHERAPY FOR PATIENTS WITH BORDERLINE PERSONALITY DISORDER - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0193953X05701519", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "Title: CLINICAL GUIDELINES FOR PSYCHOTHERAPY FOR PATIENTS WITH BORDERLINE PERSONALITY DISORDER - ScienceDirect\n# CLINICAL GUIDELINES FOR PSYCHOTHERAPY FOR PATIENTS WITH BORDERLINE PERSONALITY DISORDER. The definition tightened from the imprecise descriptors of Stern,35 emphasizing emotional collapse", "score": 0.7460282477565179 }, { "number": 10, "title": "A network analysis of DSM-5 avoidant personality disorder diagnostic criteria", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0191886921008333", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "Previous article in issue\n Next article in issue\n\n## Keywords\n\nAvoidant personality disorder\n\nNetwork analysis\n\nIsing model\n\nCentrality\n\nSCID-5-SPQ\n\nSorry, something went wrong. Please try again and make sure cookies are enabled\n\nRecommended articles\n\n## Cited by (7)\n\n ### Unlocking the core: A ", "score": 0.39494804 }, { "number": 11, "title": "Pharmacological interventions for people with borderline personality disorder - Stoffers-Winterling, JM - 2022 | Cochrane Library", "detail": "www.cochranelibrary.com", "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012956.pub2/full", "authors": "www.cochranelibrary.com", "host": "www.cochranelibrary.com", "snippet": "Compared with placebo, medication may have little to no effect on BPD symptom severity, although the evidence is of very low certainty (antipsychotics: SMD ‐0.18, 95% confidence interval (CI) ‐0.45 to 0.08; 8 trials, 951 participants; antidepressants: SMD −0.27, 95% CI −0.65 to 1.18; 2 trials, 87 pa", "score": 0.98089 }, { "number": 12, "title": "Borderline Personality Disorder in Adolescence | Pediatrics", "detail": "publications.aap.org", "url": "https://publications.aap.org/pediatrics/article/134/4/782/32909/Borderline-Personality-Disorder-in-Adolescence", "authors": "publications.aap.org", "host": "publications.aap.org", "snippet": "Borderline personality disorder (BPD) is a common and severe mental disorder that is associated with severe functional impairment and a high", "score": 0.97787 }, { "number": 13, "title": "Pharmacological interventions for people with borderline ...", "detail": "www.cochranelibrary.com", "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012956.pub2/references", "authors": "www.cochranelibrary.com", "host": "www.cochranelibrary.com", "snippet": "Prevention and early intervention for borderline personality disorder: current status and recent evidence. British Journal of Psychiatry 2013;Supplement(54):", "score": 0.94794 }, { "number": 14, "title": "Avoidant Personality Disorder in Individuals with Generalized Social Anxiety Disorder: What Does It Add? - PMC", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417304?term=%22J+Anxiety+Disord%22%5Bjour%5D", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "Title: Avoidant Personality Disorder in Individuals with Generalized Social Anxiety Disorder: What Does It Add? - PMC\nAvoidant Personality Disorder (AvPD) has a high level of symptom overlap and comorbidity with Generalized Social Anxiety Disorder (GSAD). In the past decade, the clinical utility of ", "score": 0.7006569621420754 }, { "number": 15, "title": "Diagnostic accuracy of severity measures of ICD-11 and DSM-5 personality disorder: clarifying the clinical landscape with the most up-to-date evidence", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10265646", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "| 10. Christensen et al. (38) | LPFS (SCID-5-AMPD Module I) / Criterion A algorithms | 275 (192 PD/83) / 275 (71 BPD/204); 275 (80 AVPD/195); 275 (30 ASPD/245); 275 (21 OCPD/254) | 64.5% | 33 | DSM-5 severity | Clinical judgment based on any PD of DSM IV | ≥1.5 / any two of central components | 0.79", "score": 0.5746579 }, { "number": 16, "title": "The Differential Profile of Social Anxiety Disorder (SAD) and Avoidant Personality Disorder (APD) on the Basis of Criterion B of the DSM-5-AMPD in a College Sample", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6839665", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "0.93 (detachment and negative affectivity) and 0.94 (antagonism and psychoticism). Also, Cronbach’s alphas for the 25 trait facets were acceptable, ranging from 0.70 to 0.94 that reported in Table 1. [...] 23.Reich J. Avoidant personality disorder and its relationship to social anxiety disorder. _So", "score": 0.54201555 }, { "number": 17, "title": "A Psychometric Analysis of the Structured Clinical Interview for the DSM-5 Alternative Model for Personality Disorders Module I (SCID-5-AMPD-I): Level of Personality Functioning Scale", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8167914", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "functioning, is not defined in ICD-11. Second, it appears that the severity levels in ICD-11 are not fully compatible with the severity levels in _DSM-5_. That is, mild PD in ICD-11 seems less severe than moderate impairment in the AMPD; moderate PD seems less severe than severe impairment; and seve", "score": 0.5114976 }, { "number": 18, "title": "Avoidant Personality Disorder - StatPearls - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK559325", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "To obtain a formal diagnosis of AVPD, individuals must meet the diagnostic criteria specified in the DSM-5-TR. The diagnosis involves a thorough evaluation that considers multiple sources of information, including personal history, collateral information, and a mental status examination. This compre", "score": 0.45028743 }, { "number": 19, "title": "Avoidant personality disorder: current insights", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5848673", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "was relatively high from baseline to 24 months (_r_=0.58). Ten years after baseline, stability of a diagnosis of AVPD was estimated at _r_=0.51.20 [...] SAD groups that they view as inconsistent with a severity continuum.6,9,21,25,64–67 [...] It was originally thought that AVPD occurred only in asso", "score": 0.4436251 }, { "number": 20, "title": "Avoidant Personality Disorder", "detail": "pubmed.ncbi.nlm.nih.gov", "url": "https://pubmed.ncbi.nlm.nih.gov/32644751", "authors": "pubmed.ncbi.nlm.nih.gov", "host": "pubmed.ncbi.nlm.nih.gov", "snippet": "by TJ Torrico · 2025 · Cited by 3 — Avoidant personality disorder (AVPD) is characterized by a persistent pattern of social anxiety, heightened sensitivity to rejection, and", "score": 0.42605945 }, { "number": 21, "title": "Examination of DSM-5 Section III avoidant personality ...", "detail": "pubmed.ncbi.nlm.nih.gov", "url": "https://pubmed.ncbi.nlm.nih.gov/28703479", "authors": "pubmed.ncbi.nlm.nih.gov", "host": "pubmed.ncbi.nlm.nih.gov", "snippet": "by M Sellbom · 2017 · Cited by 18 — The current research evaluated the continuity between DSM-5 Section II and Section III diagnostic operationalizations of avoidant", "score": 0.2730451 }, { "number": 22, "title": "Personality Disorder - StatPearls - NCBI Bookshelf - NIH", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK556058", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "Personality disorders reflect an enduring pattern of inner experience and behavior that deviates markedly from the norms and expectations of the surrounding culture. Individuals with personality disorders may experience distorted perceptions of reality and abnormal affective responses. The diagnosis", "score": 0.24296416 }, { "number": 23, "title": "PSYCHOLOGICAL AND PSYCHOSOCIAL TREATMENTS IN THE MANAGEMENT OF BORDERLINE PERSONALITY DISORDER - Borderline Personality Disorder - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK55410", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "Cognitive behavioural therapy (CBT) is a structured psychological treatment that focuses on helping a person make connections between their thoughts, feelings and behaviour. CBT was originally developed as a treatment for depression, and has since been modified for the treatment of people with perso", "score": 0.4450718 }, { "number": 24, "title": "The role of avoidant and obsessive-compulsive personality disorder traits in matching patients with major depression to cognitive behavioral and psychodynamic therapy: A replication study", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165032715310752", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "Cognitive behavioral therapy (CBT) and psychodynamic-interpersonal psychotherapies are two of the most widely used psychological treatments for depression. CBT aims at alleviating depressive symptoms by changing maladaptive thought schemata and errors in thinking in combination with engaging in more", "score": 0.47928494 } ], "publishedAt": "2026-08-24T18:39:36.140032+00:00", "updatedAt": "2026-08-24T18:39:36.140032+00:00", "readingMinutes": 7, "slug": "avoidant-personality-disorder" }